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EFFECTS OF ASPIRIN ON MYOCARDIAL ISCHEMIC INJURY
MEASURED BY ST-SEGMENT MAPPING
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ABSTRACT

Cardiac prostaglandin (PG) release occurs after coronary
occlusion.

Indomethacin, which inhibits cardiac PG synthesis,

has been shown to increase enicardial ST-segment elevation (STt )
over ischemic myocardium.

In vitro data suggest that acetyl-

salicylic acid (aspirin) may not affect myocardial PG synthetase,
but inhibits PG in other tissues.

This study examines the

effects of aspirin on STt after left anterior descending (LAD)
coronary occlusion in 15 open-chest dogs, compared to 5 con¬
trols.

Aspirin (either 30 mg/kg, IV or 60 mg/kg, IV) or saline

was infused at 63 min after occlusion.

Sum of ST (S ST) and

number of sites with 2 nm ST± (NST) were recorded at 60, 75, and
90 min.
2 ST (mean - SEM) was not significantly affected at 75 min
by either 30 mg/kg or 60 mg/kg of aspirin (Control, 2.53 ± 0.28$
30 mg/kg, 3.24 ±0.17; 60 mg/kg, 4.81 ±0.51, p<0.01)*

Nor was

NST significantly affected (Control, 4.00 ±0.26; 30 mg/kg,
6.00±0.14; 60 mg/kg, 5.00±0.35, p<0.01).

Results at 90 min

were similar for both lST and NST.
Thus, unlike indomethacin, aspirin does not affect 1ST or
NST.

This may be due to membraneeffects or drug-specific dif¬

ferences in the inhibition of myocardial or vascular PG.

PG History
The history of prostaglandins began with the observations
made by Kurzrok and Lieb (1930), both American gynecologists,
that preparations of human uterus either relax or contract when
exposed to human semen.

A few years later in Sweden, Euler

(1936) reported that seminal fluid and the accessory reproductive
glands produced both smooth muscle contracting and vasodepressor
activity.

Similar work was done independently in England by

Goldblatt (1935).

Euler succeeded in identifying the active

fraction of this material as a lipid-soluble acid.

He named it

"prostaglandin" as an acknowledgement to its source, the prostate
gland.
An interval of twenty years was then necessary to develop
techniques which showed that the prostaglandins were actually
a family of compounds.

These technical advances allowed

Bergstrom and Sjovall in 1957 to isolate two prostaglandins,
prostaglandin E^ (PGE) and PGF]a , in crystalline form.
years later their structure was elucidated.

Five

Eventually several

members of the family were characterized.
With an understanding of the general structure of prosta¬
glandins their relationship to essential fatty acids became
obvious.

It was then realized that acidic lipid autocoids of

several different tissues were in fact prostaglandins.

Finally,

in 1964, Bergstrom with his group and Van Doys together with his
associates independently synthesized PGE2 from arachidonic acid
obtained from homogenates of the vesicular glands of sheep
(Samuelsson, 1972).
PG Chemistry
The prostaglandins are a family of compounds which can be
considered derived from a hypothetical compound with the trivial
name prostanoic acid and has the following structure (Goodman
and Gilman, 1975):

The different classes of prostaglandins are determined by
the constituents of the cyclopenrane ring.

These are shown

for prostaglands of the E and Fa series:

These are considered the "primary prostaglandins" since they are
the most abundant and most intensively studied.
other classes:

Fg , A, B, C, and D.

There are five

These main classes are

further subdivided according to the number of side chains with
double bonds.

This is denoted by the subscript 1, 2, or 3, and

reflects the fatty acid precursor.

Those derived from 5,8,11,14-

eicosatetraenoic acid (arachidonic acid), for example, carry the
subscript 2.
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PG Biosynthesis
Prostaglandins can be found in all of the body's tissues.
They are drived ultimately from linoleic acid (cis-5, cis-3octadecadienoic acid) the main natural essential fatty acid which
can be produced only be vegetable tissue and so must be incorporated
in the diet.

It is believed that linoleic acid is deposited into

cell membranes as esterified forms of dihomo-y-linolenic acid
and arachidonic acid.

These precursor fatty acids depend on the

enzyme phospholipase a for their release from the cellular phos¬
pholipid stores when needed as substrate.

Other factors, including

oxygen and glutathion, are essential for biosynthesis.

This

released precursor fatty acid, e.g. arachidonic acid, is then
acted on in a stepwise manner by a complex of microsomal enzymes
referred to as "prostaglandin synthetase".

A cyclic peroxide

derivative, endoperoxide, is formed from unesterified precursor
acid by oxygenation and cyclization.

It is then either isomerized

to a PGE compound by endoperoxide isomerase or reduced to a PGFa
compound by endoperoxide reductase.

With arachidonic acid, then,

the products are either PGE2 or PGF9a.
abundant mammalian prostaglandins.

These are the most

The other prostaglandins, A,

B, and C, are formed from PGE by dehydration and isomerization
and is species dependent (Samuelsson, 1972; Hamberg and Samuelsson,
1973).
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PG Catabolism

Prostaglandins E and F are relatively stable in blood apart
from the slow isomerization that occurs between then.

They are,

however, rapidly inactivated and degraded by tissue-bound enzymes,
notably 15-hydroxy-prostaglandin dehydrogenase and A-13 prostaglandin
reductase, with some ninety to one hundred per cent being destroyed
during a single passage through the liver or the lungs (Ferreira,
1S67).

This implies then, that prostaglandins should not be

considered as circulating hormones, and in fact, their concentration
in circulating plasma are extremely low.

Their physiological

activities are thus on the cellular level and are probably limited
to the organ where they are produced.

PGAs are an exception,

however, in that substantial amounts escape degradation in the
pulmonary and hepatic circulation and their effects are more pro¬
longed (Horton, 1969).

PG Mechanism of Action
The way in which the prostaglandins exert their effects has
been elucidated only partially.

Current thought revolves around

two major factors involved in regulation of cellular function,
namely, calcium and cyclic AMP,

Receptors for prostaglandins are

apparently involved (Weeks, 1972).
prostaglandin are calcium dependant.

Many of the observed effects of
In most tissues prostaglandins

(especially PGE) increases the concentration of 3',5'-AMP and in
a few (adipose tissue, uterus) it lowers the concentration.

It is

thought that these effects of prostaglandins are mediated by adenylate
cyclase.

Cardiovascular Pharmacological Properties of PG
The pharmacological effects of prostaglandins are many
and varied and depend on the species and on the specific prosta¬
glandin.

No other class of autacoids has been found to have

such diverse effects.
Since the cardiovascular system is of particular interest
in this paper, our emphasis will be limited to it.

PGEs and

PGAs are potent vasodilators in most vascular beds in most species
including the coronary bed of the dog.

The dilation seems to

involve arterioles, precapillaries, sphincters, and postcapillary
venules.

Bloor and co-workers found that "in the intact un¬

anaesthetized dog PGA, and PGE, significantly increased coronary
blood flow before affecting heart rate, cardiac output and mean
aortic blood pressure, or peripheral vascular resistance"
(Bloor,

1973).

They concluded that PGA^ and PGE]_ are primary

coronary vasodilators.

Needleman and his group found that most

potent vasoconstrictor substance in the body, Angiotensin II,
produced coronary dilation when it resulted in the release of a
prostaglandin-like substance by the heart.

Coronary dilation

produced by bradykinin also appeared to be mediated by endogenous
coronary biosynthesis of a prostaglandin-like substance (Needleman,
1975).

Cardiac output is generally increased by PGs E, F, and A.
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PGs E and A also generally cause a fall in systemic blood pressure
and blood flow is increased to most organs including the heart.
An increase in myocardial, contractile force in dogs with
an intact circulation has been noted with PGE- and PGF- compounds
(Gudbjarnason, 1975).

The positive inotropic action of PGE-

compounds is not blocked by propranolol (Bergstrom, 1968; Nakano,
1971; Gudbjarnason, 1975).
Capillary permeability is increased by PGs of the E and F
series.

PGE2 may have antiarrhythmic properties according to some

studies (Mest, 1973).

Physiologic Role of Endogenous PG
Limas and Cohn (1973) have reported that the myocardium
possesses the necessary enzymatic machinery for the in situ pro¬
duction of prostaglandins.

They found that the microsomal-fraction

prepared from canine myocardium contained an active prostaglandin
synthetase which was capable of forming PGE2 from arachidonic acid
in the presence of reduced glutathione and cofactors such as
1-adrenaline, hydroquinone, and p-araino-phenol.

The mechanisn

that turns on the biosynthetic enzyme was not determined.

Previously,

however, McGiff and his co-workers had shown that a prostaglandin¬
like substance was released from the kidney during renal ischemia
(McGiff, 1970).

Similar implications of a prostaglandin role in

vasomotor autoregulation have been shown in other tissues including
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kidney (Herbaczynska-Cedro, 1974), brain (Pickard, 1973), and
uteroplacental bed (Franklin, 1975).

The biosynthesis and release

of prostaglandins into the blood stream under hypoxic conditions
was demonstrated in the isolated perfused rabbit heart in 1974
(Wenmalm, 1978) and 1957 (Block, 1975).

Similar findings were

noted in the open-chest dog where an increase in prostaglandins
in coronary venous blood were noted during postocclusive reactive
hyperemia (Alexander, 1975).

Coronary occlusion in the canine

heart-lung preparation has produced similar results (Kraemer, 1973).
The conclusion of researchers in this area was that prostaglandins
may be involved in the autoregulatory response of the myocardium
to ischemia.

Hutton (1973) demonstrated that in comparison to the

preinfarction state, prostaglandin E increased coronary blood flow
to ischemic areas.

Berger (1977) demonstrated the release of

prostaglandins E and F from the canine heart during coronary
occlusion and the release of prostaglandin F from the human heart
during pacing-induced angina pectoris.

Like Hoor and Vergroesen

(1975) we must conclude that prostaglandins are most probably
involved in the regulation of coronary flow under normal and hypoxic
conditions.

Aspirin Inhibition of PG Synthesis
A group of workers in England, led by Vane, discovered in
1971 that aspirin-like drugs inhibited the biosynthesis of prosta-
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glandins.

The evidence suggested that aspirin-like drugs

specifically inhibit the enzyme system which synthesizes prosta¬
glandins,

i.e.

prostaglandin synthetase (Vane,

supported these findings (Smith,
spect,

however,

1971;

1971).

Ferreira,

Other groups

1971).

several earlier clues had been noted.

In retro¬
Piper and

Vane (1969) had noted that a substance released by guinea pig lungs
during anaphylaxis, which they named rabbit aorta constrictor
substance (RCS),

was blocked by aspirin.

Responses to arachidonic

acid in some preparations were also inhibited by aspirin,
arachidonic acid was found to release RCS.

and

Men treated with con¬

ventional doses of aspirin demonstrated a clear-cut

inhibition of

prostaglandin synthesis as measured by the prostaglandin content of
semen or excretion of its principle metabolite in the urine.
evidence,

then,

The

clearly demonstrates that aspirin is an effective

inhibitor of prostaglandin synthesis and release.
Platelet aggregation in response to injured blood vessels
is mediated by several mechanisms of which at least two are thought
to be inhibited by aspirin.

Exposed connective tissue causes

platelets to initially aggregate at the site of injury in part
through the enzymatic action of collagen glucosy1-transferase which
can be found in platelet membranes.
activity.

Aspirin interferes with this

As they aggregate the platelets synthesize and release

thromboxane A2,

an enzymatic product of PGH2 (cyclic endoperoxide)

the intermediate between arachidonic acid and the other prostaglandins.

This thromboxane causes further aggregation and the release of
vessicle stored adenosine diphosphate (ADP).

ADP causes more

platelet aggregation with its ensuing ADP release setting in motion
a chain reaction leading to a platelet plug.

Aspirin blocks the

release of ADP by interfering with the synthesis of thromboxane A2
and aborts the entire process (Goodman and Gilman, 1975; Christ
and Van Dorp, 1972).

ST-Segment Mapping
It has been known since 1920 that myocardial injury in a
patient with coronary heart disease is indicated by ST-segment
changes in the peripheral electrocardiogram (Pardee, 1920).

Thirteen

years later Wilson and his group confirmed that ST-segment alterations
occur with coronary artery ligation by placing an electrode on the
epicardial surface of the dog heart (Wilson, 1933).

Recently, ST-

segment mapping has had wide application in confirming and quanti¬
fying regional myocardial ischemia.

The assumption has always been

that previous clinically and empirically derived relationships
between precardial electrogram alterations in the ST-segment and
the presence of ischemic myocardium are equally applicable to inter¬
pretation of changes recorded from the epicardial surface.

Sampson

(1959) suggested that the ST-segment alteration appears to be
related to an incomplete depolarization or an early repolarization
of the ischemic tissue during electrical systole.
There is considerable evidence that the epicardial ST-segment
elevation directly reflect myocardial cellular injury (Maroko, 1971).

i

n

Maroko (1971) obtained results which demonstrate a close corre¬
lation between the extent and magnitude of early elevation of STsegments in epicardial recordings after acute coronary artery
occlusion and the later development of cellular damage, as evidenced
by depression of myocardial CPK activity in specimens from the
same site.
To attribute change in ST-segments exclusively to alterations
due to ischemia would be misleading (Braunwald, 1976).
however, profoundly influenced by perfusion.

It is,

Other variables such

as PO2, PCO9, ventricular conduction, sympathetic stimulation, and
varying vectors established by the three dimensional geometry of
the ischemic myocardium affect ST-segment elevation changes.
Kjekshus and co-workers, nevertheless, established a good correlation
between the ST-segment changes and the balance between myocardial
oxygen supply and demand with subsequent evolution of myocardial
necrosis (Kjekshus, 1972).
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Materials and Methods
These experiments were designed to evaluate the effects
of inhibition of prostaglandin synthesis by acetylsalicylic acid
(aspirin) on myocardial ischemia as measured by ST-segment elevation
(ST t).
Thirty healthy dogs of both sexes, weighing fifteen
through thirty-six kilograms, were initially anesthetized with
Surital (Thiamylal 4%, 0.5 ml/kg), intubated, and mechanically
ventilated on room air (Harvard model 607).

Anesthesia was then

continued with Chlorolose-urethane (4.5 g urethane, 0.45 g
chlorolose.

Respiratory settings were manipulated to maintain the

pH, oxygen tension (PO2), and carbon dioxide tension (Pco2) of the
arterial blood gases within the following ranges:
PO2 95 to 115 rrmHg, and PC02 25 to 35 mriHg.

pH 7.35 to 7.45,

Changes were not made

in these parameters after coronary artery occlusion.
A left thoracotomy was performed in the fourth left inter¬
costal space by gross dissection and electrosurgery.
was then suspended in a pericardial cradle.

The heart

The left anterior

descending artery (LAD) was dissected free approximately 3 cm from
its origin and isolated.
LAD.

A snare was placed loosely around the

The left atrium was then cannulated and catheters inserted

into both right and left femoral arteries and the left femoral vein.
Two thousand U heparin IV was administered to every animal.

Arterial

pressures were recorded with a physiological pressure transduced
(Statham, Model No, P23Gb) and the lead II electrocardiogram was

monitored continuously.

All recordings were done on a DR-12

Electronics for Medicine multichannel recorder.

A bolus of

Lidocaine (50 mg) was given just prior to occlusion.

All animals

were then placed on a Xylocaine drip (1 mg/min).
Regional myocardial blood flow was measured using micro¬
spheres labelled with cerium-141, strontium-85, and chromium-51.
The results of these data are presented elsewhere (H. Johnson,
1979).
Epicardial ST-segment mapping was performed according to the
method described by Maroko (1971).

The epicardial electrograms

were recorded on unipolar leads at a sensitivity of 1 millivolt
per nm amplitude from approximately eighteen sites on the anterior
surface of the left ventricle by means of a saline-soaked cotton
wick electrocardiographic probe.

Sites for mapping were chosen from

areas supplied by the occluded artery and from areas remote from it
that were supplied by the left circumflex artery and which were
presumably normally perfused.

ST-segment elevation was measured

100 msec from beginning of the QRS complex.
considered the isoelectric line.

The T-P segment was

The mean of five complexes was

used as the value for each electrode site. Sites demonstrating a
QRS complex of greater than 65 msec in duration were held to be
manifestations of local conduction disturbances and were therefore
excluded from analysis for the entire experiment.
in approximately 12% of mapping sites.

This occurred

The sum of the average ST-

segment elevation for each site and the number of sites with STsegment elevation exceeding two millivolts were determined.
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Arterial blood gases were monitored and salicylate levels
were obtained from blood samples drawn after the occlusion.
Clinical laboratory measurements of serjm aspirin levels showed
that 30 mg/kg of aspirin injected as an IV bolus produced a mean
salicylate level of 10 mg/dl (range G-14) 17 min later while
60 mg/kg produced a mean salicylate level of 19.6 mg/dl (range 14-23).

Protocol
The animal model was prepared as described above and STsegment maps were made.

The left anterior descending coronary

artery was then occluded.

At 30 and 55 min post occlusion regional

myocardial blood flow was measured and epicardial ST-segment mapping
was performed.

Then, at 63 min post occlusion ten dogs received

30 mg/kg aspirin IV: five dogs received 60 mg/kg aspirin; and five
dogs received only the aspirin vehicle, 50 ml of buffered saline.
Ten additional dogs died after occlusion but before administration
of aspirin or the vehicle.
data analysis.

These animals were excluded from the

Both regional myocardial blood flowmeasurenents and

epicardial ST-segment mapping were performed again at 75 and 90
min post occlusion.

Arterial blood gases and salicylate levels

were obtained at 80 min post occlusion.
At 95 minutes the heart was excised rapidly and used in
the determination of regional blood flow.

-14-

Statistical

Methods

Data from the animals treated with 30 mg/kg of aspirin
and 60 mg/kg of aspirin were each compared to those treated with
the saline alone at 60, 75, and 90 minutes after occlusion by
unpaired t-test.

Post occlusion values obtained before and after

the administration of aspirin were also compared within each
experimental dosage level by unpaired t-test.

Probability (p)

less than 0.01 was considered significant.

Results
Heomdynamic measurements, mean aortic blood pressure and
heart rate, were not significantly altered by occlusion or aspirin
administration.

When analysed as the double product, blood pressure

multiplied by heart rate, the values for the control animals at
60, 75, and 90 min after occlusion (meant S.D. in units of
run Hg X beats X 10*), 20.4±1.0, 20.0±0.8, 20.4±2.0, were not
min
significantly different from those of the animals receiving aspirin,
19.6±1.6, 20.2±1.8, 19.2±1.6.
Values for ZST obtained by the. dogs given the aspirin vehicle
only, the control animals, at 60, 75, and 90 min were:
in units of mV) 3.51t0.31, 2.53t0.28, 2.49t0.33.
30 mg/kg aspirin had values which were:

(meant S.E.M.

The dogs receiving

3.62±0.19, 3.24t0.17,

3.86t0.25.

Those which were given 60 mg/kg: 2.68t0.29, 4.81±0.37,

3.67t0.37.

Thus the values obtained at 60 min post coronary occlusion

but before the administration of aspirin for the sum of ST-segment
elevation wore not significantly different (p<0.01) from those

-15-

obtained at either 75 min post occlusion, i.e. 13 min after
aspirin administration, or 90 min post occlusion.

Myocardial

ischemic injury as measured by ST-segment elevation (1ST) is not
affected by acetylsalicylic acid (aspirin) at either 30 mg/kg or
60 mg/kg.
A similar lack of significant difference was noted for
the number of sites measured with greater than 2 mV ST-segment
elevation (NST).

Again, the values for the control animals

4.00^:0.26, 4.00±0.26, 3.40±0.30 were not significantly different
from the animals receiving 30 mg/kg aspirin: 6.40±0.13, 6.00±0.14,
6.14±0.25 or those receiving 60 mg/kg: 4.80±0.32, 5.00±0.35,
4.60±0.32.

-16-

DISCUSSION

Berger's study (1977) demonstrated the release of prosta¬
glandins E and F from the canine heart during myocardial ischemia.
The release occurred within 10 minutes of left anterior descending
occlusion in all animals and persisted until the animal died.
Kirmser (1976) demonstrated that if Indomethacin, which
is known to block prostaglandin synthesis, is given after coronary
occlusion in an identical preparation, flow to ischemic zones
falls and ST-segment elevation increases.
Nevertheless, the exact physiologic importance of cardiac
prostaglandin release during ischemia retains unclear, although
it is thought that its local availability following a decrease in
coronary perfusion may affect the cardiac response to ischemia.
In 1977, Ogletree found that Indomethacin pretreatment pre¬
vented increases in cardiac prostaglandin release, but it did not
influence other biochemical changes or the electrocardiographic
response to ischemia.

Specifically, Indomethacin did not alter

the degree of ST-segment deviation at any time, according to that
study.
The data for aspirin are similarly conflicting.

In 1973,

Flower and others showed that aspirin inhibits the enzyme system
which synthesizes prostaglandins in many tissues.

In the same

year, however, there was a report that aspirin did not influence

the invitro activity of isolated myocardial prostaglandin synthe¬
tase (Limas, 1973).

Halushka (1977) has shown that doses of 30

mg/kg IV of aspirin in dogs completely block platelet aggregation
and platelet arachidonic acid metabolism but have no affect on myo¬
cardial synthesis of irrmunoreactive prostaglandin E-like material.
H. Johnson (1979) has shown in our preparation that following
coronary occlusion there is a fall in coronary flow which then gradually
recovers normal control levels in animals receiving no intervention.
Aspirin, however, resulted in a decrease in coronary flow to moderately
ischemic and severely ischemic zones.

There was also a concomitant

decrease in the endocardial-epicardial perfusion ratio.

Similar

results have been obtained with Indomethacin (Kirmser, 1976) suggesting
that both drugs have similar affects on coronary flow.
Kjekshus (1972) has argued convincingly that ST-segment changes
are a reliable index of myocardial ischemia.

Ung (1976), using the

criterion of ST-segment changes, concluded that aspirin pretreatment
reduces the extent of ischemic injury in the open-chest dog following
acute coronary occlusion.

In his protocol, however, the animals were

used as their own control with aspirin given before a second coronary
occlusion.

This represents a substantial difference from our procedure

and may explain the disparity in results.

In our experiments there

v/ere no significant changes in iST or NST following aspirin adminis¬
tration in post-coronary occlusive animals, possibly suggesting that
abolishing platelet prostaglandin synthesis does not affect the myo¬
cardial response to coronary occlusion.
The enzymes responsible for cardiac prostaglandin biosynthesis
may be differentially insensitive to inhibition by aspirin (Limas, 1973).

Perhaps we are seeing the competing effects of platelets and
coronary flow both of which are moderated b37 prostaglandins.
Aspirin is now being used by some researchers as a prophylactic
to prevent coronary artery thrombosis.

The experiments by Ung

(1976) suggest amelioration of the effects of coronary occlusion.
However,

it may not since our results indicate that aspirin does

not reduce the extent of ischemic injury in the open-chest dog
following acute coronary occlusion, and that it decreases regional
flow.

Thus, despite similar effects on coronary flow, aspirin

and Indomethacin have different effects on epicardail ST-segment
elevation.

This may be due either to dose or to drug-specific

differences in the inhibition of myocardial prostaglandin.

TABLE I
1ST (mV)

Time Post
Occlusion

Aspirin
dose

Mean

Standard
deviation

Standard
error

60 min

control
30 mg/kg
60 mg/kg

3.51
3.62
2.68

3.06
2.66
2.90

0.31
0.19
0.29

75 min

control
30 mg/kg
60 mg/kg

2.53
3.24
4.81

2.82
2.47
5.13

0.28
0.17
0.51

2.49
3.87
3.67

3.27
2.98
3.73

0.33
0.25
0.37

90 min

control
30 mg/kg
60 mg/kg

TABLE 2
NST

Standard
error

Time Post
Occlusion

Aspirin
dose

Mean

Standard
deviation

60 min

control
30 mg/kg
60 mg/kg

4.00
6.40
4.80

2.61
1.91
3.25

0.26
0.13
0.23

75 min

control
30 mg/kg
60 mg/kg

4.00
6.00
5.00

2.61
2.00
3.52

0.26
0.14
0.35

90 min

control
30 mg/kg
60 mg/kg

3.40
6.14
4.60

3.01
3.00
3.20

0.30
0.25
0.32
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